An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients-Reference-Cited by-同舟云学术

An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients

Published:2008-12 Issue:6 Volume:30 Page:662-669
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

D'Avolio Antonio,Baietto Lorena,Siccardi Marco,Sciandra Mauro,Simiele Marco,Oddone Valentina,Bonora Stefano,Perri Giovanni Di

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference38 articles.

1. Darunavir: an overview of an HIV protease inhibitor developed to overcome drug resistance.;Taiwo;AIDS Read,2007

2. Integrase inhibitors: A new treatment option for patients with human immunodeficiency virus infection.;Correll;Pharmacotherapy,2008

3. Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection- results of a 48-week controlled study.;Markowitz;JAIDS,2007

4. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.;Andries;Antimicrobial Agents and Chemotherapy,2004

5. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.;Lazzarin;Lancet,2007

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring of antiretroviral drugs for the management of human immunodeficiency infection;Therapeutic Drug Monitoring;2024

2. Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study;The Pharmacogenomics Journal;2022-10-20

3. Analytical Techniques for the Analysis of Lopinavir and Ritonavir in Pharmaceutical Dosage Form and Biological Matrices: A Review;Current Pharmaceutical Analysis;2021-12-17

4. Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz;Nutrients;2021-10-12

5. Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring;Biomedicines;2021-09-12